Inovio Pharmaceuticals, Inc.
(NASDAQ : INO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Loading INO News...
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories
1.12%45.590.8%$412.75m
MDTMedtronic PLC
1.50%82.120.7%$397.05m
TMOThermo Fisher Scientific Inc.
1.45%159.961.2%$284.84m
EWEdwards Lifesciences Corporation
-0.47%93.601.2%$264.35m
BSXBoston Scientific Corporation
1.39%24.891.3%$260.33m
ISRGIntuitive Surgical, Inc.
0.54%740.989.3%$242.02m
BDXBecton, Dickinson and Company
1.45%185.701.7%$164.62m
ZLTQZELTIQ Aesthetics, Inc.
0.17%55.4622.8%$162.59m
ZBHZimmer Biomet Holdings, Inc.
1.54%118.882.0%$160.19m
BAXBaxter International Inc.
0.43%51.141.6%$144.39m
SYKStryker Corporation
1.45%130.422.1%$144.06m
BCRC. R. Bard, Inc.
0.99%247.671.5%$135.36m
CYNOCynosure, Inc. Class A
0.27%66.1822.1%$128.03m
IDXXIDEXX Laboratories, Inc.
2.04%147.903.6%$127.84m
XRAYDENTSPLY International Inc.
1.09%64.213.6%$115.33m

Company Profile

Inovio Pharmaceuticals, Inc. is a bio-pharmaceutical company, which develops active DNA immunotherapies for cancer and infectious diseases. Its portfolio of immune therapies includes SynCon immunotherapies and electroporation delivery systems. The company was founded on June 29, 1983 and is headquartered in Plymouth Meeting, PA.